Clinical trial
Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34
NCT00001304 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00001304 |
|---|---|
| Title | Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 |
| Official title | Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypoparathyroidism |
| Intervention type | Drug |
| Interventions | Synthetic Human Parathyroid Hormone 1-34, Calcitriol & Calcium |
| Enrollment | 27 |
| Start date | Oct 1, 1991 |
| Primary completion | Mar 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 15, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: